Regulation of Progenitor Cell Fusion by ABCB5 P-glycoprotein, a Novel Human ATP-binding Cassette Transporter*

Cell fusion involving progenitor cells is a newly recognized phenomenon thought to contribute to tissue differentiation. The molecular mechanisms governing cell fusion are unknown. P-glycoprotein and related ATP-binding cassette transporters are expressed by progenitor cells, but their physiological role in these cell types has not been defined. Here, we have cloned ABCB5, a rhodamine efflux transporter and novel member of the human P-glycoprotein family, which marks CD133-expressing progenitor cells among human epidermal melanocytes and determines as a regulator of membrane potential the propensity of this subpopulation to undergo cell fusion. Our findings show that polyploid ABCB5+ cells are generated by cell fusion and that this process is specifically enhanced by ABCB5 P-glycoprotein blockade. Remarkably, multinucleated cell hybrids gave rise to mononucleated progeny, demonstrating that fusion contributes to culture growth and differentiation. Thus, our findings define a molecular mechanism for cell fusion involving progenitor cells and show that fusion and resultant growth and differentiation are not merely spontaneous events, but phenomena regulated by ABCB5 P-glycoprotein.

[1]  C. Bader,et al.  Acceleration of human myoblast fusion by depolarization: graded Ca2+ signals involved , 2003, Development.

[2]  M. Sayegh,et al.  P-glycoprotein--a novel therapeutic target for immunomodulation in clinical transplantation and autoimmunity? , 2003, Current drug targets.

[3]  M. Gottesman,et al.  P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential. , 2003, Cancer research.

[4]  G. Vassilopoulos,et al.  Transplanted bone marrow regenerates liver by cell fusion , 2003, Nature.

[5]  M. Grompe,et al.  Cell fusion is the principal source of bone-marrow-derived hepatocytes , 2003, Nature.

[6]  D. Prockop,et al.  Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Bischoff,et al.  AC133-2, a Novel Isoform of Human AC133 Stem Cell Antigen* 210 , 2002, The Journal of Biological Chemistry.

[8]  S. Nishikawa,et al.  Dominant role of the niche in melanocyte stem-cell fate determination , 2002, Nature.

[9]  E. Scott,et al.  Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion , 2002, Nature.

[10]  Qi-Long Ying,et al.  Changing potency by spontaneous fusion , 2002, Nature.

[11]  Sudhir Gupta,et al.  Anti-P-Glycoprotein Antibody-Induced Apoptosis of Activated Peripheral Blood Lymphocytes: A Possible Role of P-Glycoprotein in Lymphocyte Survival , 2001, Journal of Clinical Immunology.

[12]  A. Spradling,et al.  Stem cells find their niche , 2001, Nature.

[13]  A. Sadikot,et al.  Isolation of multipotent adult stem cells from the dermis of mammalian skin , 2001, Nature Cell Biology.

[14]  H. Nakauchi,et al.  The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype , 2001, Nature Medicine.

[15]  M. Andreeff,et al.  A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. , 2001, Blood.

[16]  F. Sharom,et al.  Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter. , 2001, Biochemistry.

[17]  S. Khoury,et al.  Specific MDR1 P-Glycoprotein Blockade Inhibits Human Alloimmune T Cell Activation In Vitro1 , 2001, The Journal of Immunology.

[18]  I. Weissman,et al.  Direct isolation of human central nervous system stem cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  B. Sorrentino,et al.  Effects of Retroviral‐Mediated MDR1 Expression on Hematopoietic Stem Cell Self‐Renewal and Differentiation in Culture a , 1999, Annals of the New York Academy of Sciences.

[20]  L. Doyle,et al.  A multidrug resistance transporter from human MCF-7 breast cancer cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Vincenzo,et al.  A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. , 1998, Cancer research.

[22]  C. Bader,et al.  Cloning of a human ether‐a‐go‐go potassium channel expressed in myoblasts at the onset of fusion , 1998, FEBS letters.

[23]  R. Steinman,et al.  A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. Ghanem,et al.  Modulation of ICAM‐1 expression by α‐MSH in human melanoma cells and melanocytes , 1998, Journal of cellular physiology.

[25]  J. Kearney,et al.  AC133, a novel marker for human hematopoietic stem and progenitor cells. , 1997, Blood.

[26]  R. Johnson,et al.  Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species , 1997, Nature Medicine.

[27]  I. Bosch,et al.  Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein. , 1997, Biochemistry.

[28]  Piet Borst,et al.  MDR1 P-Glycoprotein Is a Lipid Translocase of Broad Specificity, While MDR3 P-Glycoprotein Specifically Translocates Phosphatidylcholine , 1996, Cell.

[29]  A. Hutchinson,et al.  Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the expressed sequence tags database. , 1996, Human molecular genetics.

[30]  J. C. Taylor,et al.  The multidrug resistance P‐glycoprotein modulates cell regulatory volume decrease. , 1996, The EMBO journal.

[31]  S. Zhao,et al.  Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. , 1996, Blood.

[32]  M. Yoder,et al.  Isolation of primitive human bone marrow hematopoietic progenitor cells using Hoechst 33342 and Rhodamine 123. , 1996, Experimental hematology.

[33]  G. Raghu,et al.  Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes. , 1996, Experimental hematology.

[34]  A. S. Conner,et al.  Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo , 1996, The Journal of experimental medicine.

[35]  R. Willemze,et al.  Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulating ability. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[36]  D. Brooks,et al.  Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: in vivo expansion of stem cell phenotype but not function. , 1995, Blood.

[37]  P. Borst,et al.  Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease , 1993, Cell.

[38]  F. Baas,et al.  Binding properties of monoclonal antibodies recognizing external epitopes of the human MDR1 P‐glycoprotein , 1993, International journal of cancer.

[39]  T. B. Bakker Schut,et al.  Selective electrofusion of conjugated cells in flow. , 1993, Biophysical journal.

[40]  N. Wolf,et al.  In vivo and in vitro characterization of long-term repopulating primitive hematopoietic cells isolated by sequential Hoechst 33342-rhodamine 123 FACS selection. , 1993, Experimental hematology.

[41]  A. Duncan,et al.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.

[42]  M. Valverde,et al.  Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein , 1992, Nature.

[43]  D. Tenen,et al.  Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells. , 1992, Journal of immunology.

[44]  I. Roninson,et al.  Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells , 1991, Cell.

[45]  G. Spangrude,et al.  Resting and activated subsets of mouse multipotent hematopoietic stem cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[46]  F. Baas,et al.  The human mdr3 gene encodes a novel P‐glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver. , 1987, The EMBO journal.

[47]  A. Aszalos,et al.  Early plasma membrane depolarization by alpha interferon: biologic correlation with antiproliferative signal. , 1987, Biochemical and biophysical research communications.

[48]  J. Riordan,et al.  The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. , 1986, Biochemical and biophysical research communications.

[49]  D. Housman,et al.  Isolation and expression of a complementary DNA that confers multidrug resistance , 1986, Nature.

[50]  I. Pastan,et al.  Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Riordan,et al.  Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines , 1985, Nature.

[52]  B. Teicher,et al.  Antitumor alkylating agents: in vitro cross-resistance and collateral sensitivity studies , 2004, Cancer Chemotherapy and Pharmacology.

[53]  P. Borst,et al.  Mammalian ABC transporters in health and disease. , 2002, Annual review of biochemistry.

[54]  R. Johnstone,et al.  Multiple physiological functions for multidrug transporter P-glycoprotein? , 2000, Trends in biochemical sciences.